Page last updated: 2024-11-07

penicillamine and Experimental Mammary Neoplasms

penicillamine has been researched along with Experimental Mammary Neoplasms in 3 studies

Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BEREZOV, TT1
DOBRININ, YV1
Chvapil, M1
Kielar, F1
Liska, F1
Silhankova, A1
Brendel, K1
Janssens, MY1
Van den Berge, DL1
Verovski, VN1
Monsaert, C1
Storme, GA1

Other Studies

3 other studies available for penicillamine and Experimental Mammary Neoplasms

ArticleYear
THE RANGE OF TRANSAMINATION IN CARCINOMA CELLS OF MAMMARY GLAND IN TISSUE CULTURE.
    Acta - Unio Internationalis Contra Cancrum, 1964, Volume: 20

    Topics: Alanine Transaminase; Amination; Amino Acids; Animals; Aspartate Aminotransferases; Breast Neoplasms

1964
Synthesis and evaluation of long-acting D-penicillamine derivatives.
    Connective tissue research, 2005, Volume: 46, Issue:4-5

    Topics: Adenocarcinoma; Alcohols; Aminopropionitrile; Animals; Cicatrix, Hypertrophic; Collagen; Connective

2005
Activation of inducible nitric oxide synthase results in nitric oxide-mediated radiosensitization of hypoxic EMT-6 tumor cells.
    Cancer research, 1998, Dec-15, Volume: 58, Issue:24

    Topics: Animals; Cell Hypoxia; Enzyme Activation; Hydrazines; Interferon-gamma; Mammary Neoplasms, Experimen

1998